What is the listing price of Selegiline?

Selegiline/imidopyr(Selegiline) is a monoamine oxidase type B inhibitor that has been used clinically for many years and is often used to treat Parkinson's disease. As demand for the drug grows in the global market, its prices and versions are gradually diversified. According to the latest market information, the original drug Selegiline Hydrochloride Tablets has been launched in China and has been included in the National Medical Insurance Category B Catalog. Patients have a low out-of-pocket rate, which significantly reduces the economic burden of long-term treatment.

The common specifications of the original research version currently sold in China are5 mg × 100 tablets/box, and the average market retail price is about RMB 500. Since the price has been compressed to a certain extent after being included in medical insurance, the selling prices of pharmacies and hospitals in different regions vary slightly. This version is produced by an imported pharmaceutical company and has high purity and stability. It is suitable for patients with Parkinson's disease who require long-term maintenance treatment.

In overseas markets, generic selegiline hydrochloride has been produced by pharmaceutical companies in many countries, including India and parts of Southeast Asia. The main ingredient of the generic drug is the same as the original drug, which is Selegiline hydrochloride, and its pharmacological activity and absorption characteristics are similar. The specifications produced by overseas pharmaceutical companies are usually 5 mg × 100 tablets/box, and their prices are generally lower than the original drugs, about RMB 200, but factors such as exchange rate fluctuations and transportation costs need to be considered.

It is worth noting that when some patients purchase generic drugs through cross-border medical platforms or overseas regular pharmacies, they should check whether the source of the drug has GMP (Good Manufacturing Practice) certification to ensure reliable drug quality. Although generic drugs are more affordable, there are slight differences in excipients and drug release characteristics between different manufacturers, and individual tolerance and effects may be slightly different.

Overall, the global market pricing of selegiline shows a "polarization" trend: the original drug is more expensive but has stable quality, and is suitable for long-term treatment and patients with medical insurance reimbursement; generic drugs have become an economic choice for self-pay patients due to their lower cost.

Reference: https://www.drugs.com/mtm/selegiline.html